Industry News
Science at the Shine Dome 2013
Experience quantum billiards, find out how genome sequencing technology will revolutionise the practice of medicine and gain an insight into the dramatic changes the ocean is undergoing. [ + ]
Local CROs team up for international trials
Datapharm is on the expansion path for Dai-Sys, its initiative aimed at bringing together a global network of local small to mid-size CROs for international clinical trial support services. [ + ]
Industry Innovation Precincts applications open
As part of the federal government’s Innovation and Industry Policy ‘A Plan for Australian Jobs’, released in February, applications have opened for up to eight Industry Innovation Precincts. [ + ]
GTG expands US reach for BREVAGen
Genetic Technologies (ASX:GTG) signed a deal with a US health insurance network, more than doubling the ‘in-network’ reach for its BREVAGen breast cancer risk screening tool. [ + ]
Recognising excellence in health and medical research
Research Australia is calling for 2013 industry award nominations. [ + ]
Mesoblast publishes results of AMI trial
Mesoblast’s (ASX:MSB) adult MPCs were able to improve cardiac function in an animal model of acute myocardial infarction, a study shows. [ + ]
Bionomics and CTx hit cancer treatment milestone
Bionomics (ASX:BNO) and CTx said a compound from their VEGFR3 inhibitor program was able to suppress cancer progression in an animal model of melanoma. [ + ]
Agreement signed between Garvan, Cancer Therapeutics CRC and SYNkinase
The development of a new research tool for proteomics and chemical biology is set to move forward. [ + ]
Pig poo problem solved
An Australian-led project to turn 1.4 million tonnes of Chinese pig poo into alternative energy and fertiliser has been hailed in a national science award. [ + ]
Grow your own electricity
Researchers have engineered a strain of electricity-producing bacteria that can grow using hydrogen gas as its sole electron donor and carbon dioxide as its sole source of carbon. [ + ]
UQ scientist wins top prize for battling rheumatoid arthritis and tuberculosis
A Queensland medical researcher who is on the trail of genetic markers for rheumatoid arthritis and tuberculosis has won the state’s top science prize. [ + ]
UWA forms spin-out company to develop nanoparticle cancer drugs
The University of Western Australia (UWA) and Yuuwa Capital LP have set up a new spin-out company, Eridan Technology, to commercialise nanoparticle technology for drug delivery applications. [ + ]
New spin-out company to develop nanoparticle drugs
A new spin-out company has been set up by the University of Western Australia to commercialise nanoparticle drugs for biomedical applications. [ + ]
A simple step from ocean to land
The shape change required for animals to make the major evolutionary transition from ocean to land appears to have been simpler than previously thought. [ + ]
Revised code to benefit ASX-listed life science companies
The Minister for Technology, the Hon Gordon Rich-Phillips, yesterday joined forces with the Australian Securities Exchange (ASX) and Australia’s biotechnology industry association, AusBiotech, to launch a revised edition of the industry code of best practice that will support capital formation by ASX-listed life science companies. [ + ]
